EverSource Wealth Advisors LLC Reduces Stake in Encompass Health Co. (NYSE:EHC)

EverSource Wealth Advisors LLC lowered its stake in Encompass Health Co. (NYSE:EHC) by 10.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,420 shares of the company’s stock after selling 295 shares during the period. EverSource Wealth Advisors LLC’s holdings in Encompass Health were worth $202,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in Encompass Health by 1.7% in the first quarter. Vanguard Group Inc. now owns 10,166,147 shares of the company’s stock worth $839,520,000 after acquiring an additional 169,113 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Encompass Health by 5.8% during the fourth quarter. Wellington Management Group LLP now owns 8,215,770 shares of the company’s stock valued at $548,156,000 after buying an additional 449,230 shares during the period. TD Asset Management Inc boosted its position in shares of Encompass Health by 16.0% during the first quarter. TD Asset Management Inc now owns 2,283,674 shares of the company’s stock valued at $188,586,000 after buying an additional 314,488 shares during the period. Massachusetts Financial Services Co. MA boosted its position in shares of Encompass Health by 6.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,928,449 shares of the company’s stock valued at $128,666,000 after buying an additional 120,527 shares during the period. Finally, Brown Advisory Inc. boosted its position in shares of Encompass Health by 6.2% during the fourth quarter. Brown Advisory Inc. now owns 1,791,517 shares of the company’s stock valued at $119,530,000 after buying an additional 104,847 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on EHC shares. Leerink Partnrs upgraded Encompass Health to a “strong-buy” rating in a research report on Wednesday, July 10th. Raymond James restated a “strong-buy” rating and set a $95.00 target price (up previously from $85.00) on shares of Encompass Health in a research report on Friday, April 26th. Stephens reiterated an “overweight” rating and issued a $94.00 price target on shares of Encompass Health in a report on Wednesday, June 5th. SVB Leerink assumed coverage on Encompass Health in a report on Wednesday, July 10th. They issued an “outperform” rating and a $100.00 price target for the company. Finally, Mizuho boosted their price target on Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a report on Thursday, April 25th. Nine equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $96.50.

Encompass Health Stock Down 0.3 %

NYSE:EHC traded down $0.31 during trading hours on Friday, reaching $92.71. The company’s stock had a trading volume of 774,213 shares, compared to its average volume of 677,509. The company has a market capitalization of $9.33 billion, a P/E ratio of 25.06, a price-to-earnings-growth ratio of 1.45 and a beta of 0.89. Encompass Health Co. has a 12 month low of $57.55 and a 12 month high of $94.38. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.37 and a current ratio of 1.37. The stock has a 50 day moving average price of $86.32 and a two-hundred day moving average price of $81.03.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st will be paid a $0.17 dividend. This is an increase from Encompass Health’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Tuesday, October 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.73%. Encompass Health’s payout ratio is 18.38%.

Insider Buying and Selling

In other news, EVP John Patrick Darby sold 14,543 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $83.94, for a total transaction of $1,220,739.42. Following the transaction, the executive vice president now directly owns 84,773 shares of the company’s stock, valued at $7,115,845.62. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other news, insider Elissa Joy Charbonneau sold 10,000 shares of the company’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $85.02, for a total transaction of $850,200.00. Following the transaction, the insider now directly owns 18,594 shares of the company’s stock, valued at $1,580,861.88. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP John Patrick Darby sold 14,543 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $83.94, for a total value of $1,220,739.42. Following the transaction, the executive vice president now directly owns 84,773 shares in the company, valued at $7,115,845.62. The disclosure for this sale can be found here. 2.10% of the stock is currently owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.